Carol A Watson Selected Research

Peptide Hydrolases (Proteases)

1/2017

Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carol A Watson Research Topics

Disease

6	Hemorrhage 01/2017 - 12/2002
6	Thrombosis (Thrombus) 01/2017 - 12/2002
4	Carotid Artery Thrombosis 01/2009 - 12/2002
2	Weight Loss (Weight Reduction) 01/2009 - 05/2007
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017

Drug/Important Bio-Agent (IBA)

4	Clopidogrel (Plavix)FDA Link 01/2017 - 05/2007
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2014 - 12/2002
2	Factor Xa InhibitorsIBA 08/2007 - 12/2002
2	AnticoagulantsIBA 08/2007 - 12/2002
1	AntibodiesIBA 01/2017
1	BMS-986120IBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017
1	Factor XIa (Coagulation Factor XIa)IBA 02/2014
1	BMS-262084IBA 08/2011
1	Prasugrel Hydrochloride FDA Link 01/2009
1	ThienopyridinesIBA 01/2009
1	Adenosine Diphosphate (ADP)IBA 01/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2007
1	razaxabanIBA 08/2007
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2002
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2002
1	pyrazoleIBA 12/2002
1	Thrombin FDA Link 12/2002
1	1- (3- (aminomethyl)phenyl)- N- (3- fluoro- 2'- (methylsulfonyl)(1,1'- biphenyl)- 4- yl)- 3- (trifluoromethyl)- 1H- pyrazole- 5- carboxamideIBA 12/2002
1	argatroban (MPQA)FDA Link 12/2002

Therapy/Procedure

2	Therapeutics 08/2011 - 08/2007